Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rang in Aktien #28752
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Aktienkurs
$0.45018154
Marktkapitalisierung
$24.81M
Veränderung (1 Tag)
1.47%
Veränderung (1 Jahr)
-56.57%
Land
JP
Handel SymBio Pharmaceuticals Limited (4582)

Kategorie

Kursverlauf für SymBio Pharmaceuticals Limited (4582)
Höchster Schlusskurs: $0.46 am 2026-08-01

Niedrigster Schlusskurs: $17.89 am 2011-10-01
Kursverlauf der Aktie von SymBio Pharmaceuticals Limited von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 10.27%
2025 -56.52%
2024 -16.79%
2023 -65.67%
2022 -51.70%
2021 187.45%
2020 -38.01%
2019 -23.58%
2018 -2.71%
2017 -10.92%
2016 30.46%
2015 -41.83%
2014 -22.36%
2013 7.56%
2012 -7.49%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$61.63 71.19%
US
$52.00 78.68%
SE
$195.83 46.67%
FR
$119.62 70.43%
US
$62.93 3.27%
IT